论文部分内容阅读
目的:对凝血酶联合奥美拉唑治疗残胃出血的效果进行分析探讨。方法:选取我院2015年7月至2016年2月收治的100例残胃出血患者作为本次研究的对象,随机将其分为实验组与对照组,每组各50例患者。实验组采用凝血酶联合奥美拉唑的方式对组内患者进行治疗,对照组则单一使用奥美拉唑对组内患者进行治疗,待疗程结束后,对两组残胃出血患者的治疗效果进行对比。结果:实验组患者在接受凝血酶联合奥美拉唑治疗方法后,组内患者治疗总有效率为96.2%,对照组患者治疗总有效率为80%,组间差异明显,具有统计意义(P<0.05)。两组患者在治疗期间,均无出现不良反映。结论:凝血酶联合奥美拉唑治疗方法对残胃出血患者的应用效果显著,能够有效治疗残胃出血,并且在安全性上有所保障。
Objective: To analyze the effect of thrombin combined with omeprazole on residual gastric hemorrhage. Methods: 100 cases of residual gastric hemorrhage admitted from July 2015 to February 2016 in our hospital were selected as the object of this study. They were randomly divided into experimental group and control group with 50 patients in each group. In the experimental group, patients were treated with thrombin and omeprazole, while those in the control group were treated with omeprazole alone. After the treatment, the therapeutic effect on the patients with residual gastric hemorrhage comparing. Results: After receiving thrombin and omeprazole in the experimental group, the total effective rate was 96.2% in the treatment group and 80% in the control group. The difference between the two groups was statistically significant (P <0.05). Two groups of patients in the treatment period, no adverse reactions. Conclusion: The combination therapy of thrombin and omeprazole has significant effect on the patients with residual gastric hemorrhage, which can effectively treat the residual gastric bleeding and is safe in safety.